Accès ouvert
2026
preprint
OpenAlex
Rhian S. Convery, Kerala Adams-Carr, Lucy Louise Russell, Amelia Blesius et autres
gb, nl, us, it, ca, es, pt, de, be, fi
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Isis So, Jolina Lombardi, Adam M. Staffaroni, Kristy K. L. Coleman et autres
ABSTRACT Background and Objectives Converging evidence hints at neurodevelopmental effects in genetic frontotemporal degeneration (FTD). In cross-sectional studies, for some genes, young adult FTD variant carriers show differences in brain volumes and cognition compared to familial non-carriers. However, longitudinal trajectories may more …
ca, us, gb, nl, it, be, fr, fi, de, es, pt, se
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Nicole Tamvaka, William J. Scotton, Meredith T. Lilley, Maryam Shoai et autres
Abstract Genetic studies have significantly advanced our understanding of tauopathies, yet the genetic aetiology of Pick’s disease, a rare 3-Repeat tauopathy, remains unclear. The MAPT p.A152T variant has been identified as a risk factor for Alzheimer’s disease and progressive supranuclear palsy, but …
us, gb, be, hk
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Enrico Premi, Damiano Archetti, Alberto Redolfi, Valeria Bracca et autres
Abstract Individuals with autosomal dominant frontotemporal dementia (FTD) exhibit considerable variability in disease onset and progression. Both modifiable and non-modifiable factors—such as sex, educational attainment or geographic region of residence—may contribute to this heterogeneity, potentially through their influence on cognitive reserve. The …
it, us, fr, gb, nl, es, ca, se, ru, be, pt, de, hk
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Charlotte H Graafland, Eline Maria Bunnik, Barbara Borroni, Arabella Bouzigues et autres
BACKGROUND: As understanding of biomarkers for genetic frontotemporal dementia (FTD) advances, there is a need to develop onset-predictive biomarker tests (OPBTs) to detect changes before the onset of symptoms. OPBTs can be used to recruit carriers or individuals at 50% risk of …
nl, it, gb, es, fi, se
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Hülya Ulugut, Kyan Younes, Maxime Montembeault, Maxime Bertoux et autres
Accurate diagnosis of frontotemporal dementia (FTD) with right anterior temporal lobe (RATL) predominance remains challenging due to lack of clinical characterization, and standardized terminology. The recent research of the International Working Group (IWG) identified common symptoms but also unveiled broad terminologies lacking …
us, nl, ca, fr, au, it, tr, es, gb, se, de, be, br, cl, co, kr, in
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Julie F. H. De Houwer, Elise G.P. Dopper, Renee van Buuren, Marijke E. Stokkel et autres
Fluid biomarkers to diagnose frontotemporal lobar degeneration (FTLD) are currently lacking. In this study, we aimed to identify proteomic changes in CSF associated with FTLD pathogenesis, focusing on signatures unique to different genetic groups. Additionally, we sought proteins distinguishing FTLD-spectrum disorders from …
nl, gb, es, ca, se, ru, it, us, be, pt, de, fr, hk, in
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Kamen A. Tsvetanov, Maura Malpetti, Peter Simon Jones, Timothy Rittman et autres
Frontotemporal dementia (FTD) shows autosomal dominant transmission in up to a third of families, enabling the study of presymptomatic and prodromal phases. Despite self-reported well-being and normal daily cognitive functioning, brain structural changes are evident a decade or more before the expected …
gb, pt, de, it, nl, es, ca, se, ru, us, be, fr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Isis So, Arabella Bouzigues, Lucy Louise Russell, Phoebe H. Foster et autres
Background Converging evidence hints at neurodevelopmental effects in people at risk of genetic frontotemporal dementia (FTD). Objective We investigated total intracranial volume (TIV), a neuroimaging marker of neurodevelopment, and years of education differences between adult mutation carriers and familial non-mutation carriers, as …
ca, gb, nl, es, se, it, be, pt, de, fr, us
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Mahdie Soltaninejad, Yasser Iturria‐Medina, Reza Rajabli, Gleb Bezgin et autres
Abstract Predicting symptom onset in genetic frontotemporal dementia (FTD) is crucial for advancing targeted interventions and clinical trial design. Brain changes begin years before clinical symptoms emerge, making neuroimaging a strong candidate for onset prediction. However, FTD is highly heterogeneous, encompassing diverse …
ca, ae, gb, nl, es, se, it, be, pt, de, fr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Liset de Boer, Lize Corrine Jiskoot, Harro Seelaar, John Cornelis Van Swieten et autres
INTRODUCTION: We investigated international differences in facial emotion recognition (FER) across stages of frontotemporal dementia (FTD). Previous studies may have missed early decline by combining data and masking variations in FER across countries. METHODS: An FER test was administered to 159 individuals …
nl, ie, cl, gb, fr, it, ca, se, es, pt, de, be
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Taru Flagan, Stephanie A. Chu, Suvi Häkkinen, Liwen Zhang et autres
OBJECTIVE: Autosomal dominant progranulin (GRN) pathogenic variants are a genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN-related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression. We previously showed …
us, gb, ca, fr, es
(code pays fourni par la source)